[Treatment of Barrett esophagus in the XXI century: controversies and future perspectives].
Barrett's esophagus is today, one of the digestive pathologies that raises more interest in all the meetings and congresses of the specialty, in spite of have been described 50 years ago. The definition has changed; the rising incidence of adenocarcinoma has been recognized; a most effective therapy to control gastroesophageal reflux has been developed (proton pump inhibitor v/s laparoscopic fundoplication); appropriate surveillance intervals of patients with dysplasia have been protocolized; new treatment strategies are being investigating. Although, numerous controversies still persist. The exact and accurate knowledge of physiopathology constitutes the base of treatment and prevention for gastroesophageal reflux disease and their complications.